✦ LIBER ✦

Troxacitabine Prodrugs for Pancreatic Cancer

✍ Scribed by Adema, A. D.; Radi, M.; Daft, J.; Narayanasamy, J.; Hoebe, E. K.; Alexander, L. E.; Chu, C. K.; Peters, G. J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genetic Prodrug Activation Therapy for P

✍ A. S. RIGG; N. R. LEMOINE 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

Synergistic activity of troxacitabine (T

✍ Vijaya L Damaraju; David Y Bouffard; Clarence KW Wong; Marilyn L Clarke; John R 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 377 KB

In Vitro Optimization of Non-Small Cell

✍ Radi, Marco; Adema, Auke D.; Daft, Jonathan R.; Cho, Jong H.; Hoebe, Eveline K.; 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 83 KB

Computational and Biological Evaluation

✍ Pavel Pospisil; Houari Korideck; Ketai Wang; Yongliang Yang; Lakshmanan K. Iyer; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 699 KB

In vivoAdenovirus-mediated Prodrug Gene

✍ Ohashi, Makoto ;Kanai, Fumihiko ;Tanaka, Torao ;Lan, Keng-Hsin ;Shiratori, Yasus 📂 Article 📅 1998 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 202 KB

Mechanism-based pharmacokinetic/pharmaco

✍ Chee M. Ng; A. Patnaik; M. Beeram; C. C. Lin; C. H. Takimoto 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 495 KB